Разработка алгоритма для выполнения операции обратного проецирования

High Power Pulsed Magnetron Sputtering (HPPMS) techniques jointly with the deposition of a graded Cr/CrN-nanointerlayer on cutting inserts can increase the film adhesion and consequently the tool life. These improvements depend on the roughness of the employed cemented carbide substrates. The investigations described in the present paper intend to explain the effect of Cr/CrN-interlayer thickness and substrate roughness on the coating adhesion and cutting performance. To attain various roughnesses, the applied cemented carbide inserts were superficially treated. These treatments were grinding at a medium roughness level, or grinding with subsequent polishing for enhancing the surface integrity and finally, in all cases, micro-blasting by fine Al2O3 grains. After Ar-ion etching, graded Cr/CrN adhesive layers with different thicknesses were deposited by HPPMS technology on the variously pretreated substrates. Subsequently, an approximately 3m thick (Ti,Al)N film was depos ited by HPPMS PVD on all used inserts. Rockwell C indentations and inclined impact tests were performed to assess qualitatively and quantitatively the films' adhesion. The cutting performance of the coated tools was investigated in milling of 42CrMo4 QT. FEM supported calculations of the developed stresses during the material removal process contributed in explaining the obtained tool wear results. In these calculations, the adhesion, dependent on the substrate roughness characteristics and on the adhesive interlayer thickness, was taken into account. The results revealed that the effectiveness of HPPMS adhesive graded Cr/CrN-nanointerlayer strongly depends on the substrate surface integrity and on the interlayer thickness. Thus, the film adhesion and consequently the cutting performance can be significantly improved if the interlayer thickness is adapted to the substrate roughness

Genotypic diversity and phenotypic spectrum of infantile liver failure syndrome type 1 due to variants inLARS1

Purpose: Biallelic variants in LARS1, coding for the cytosolic leucyl-tRNA synthetase, cause infantile liver failure syndrome 1 (ILFS1). Since its description in 2012, there has been no systematic analysis of the clinical spectrum and genetic findings. Methods: Individuals with biallelic variants in LARS1 were included through an international, multicenter collaboration including novel and previously published patients. Clinical variables were analyzed and functional studies were performed in patient-derived fibroblasts. Results: Twenty-five individuals from 15 families were ascertained including 12 novel patients with eight previously unreported variants. The most prominent clinical findings are recurrent elevation of liver transaminases up to liver failure and encephalopathic episodes, both triggered by febrile illness. Magnetic resonance image (MRI) changes during an encephalopathic episode can be consistent with metabolic stroke. Furthermore, growth retardation, microcytic anemia, neurodevelopmental delay, muscular hypotonia, and infection-related seizures are prevalent. Aminoacylation activity is significantly decreased in all patient cells studied upon temperature elevation in vitro. Conclusion: ILFS1 is characterized by recurrent elevation of liver transaminases up to liver failure in conjunction with abnormalities of growth, blood, nervous system, and musculature. Encephalopathic episodes with seizures can occur independently from liver crises and may present with metabolic stroke

A review of metal-ion-flux-controlled growth of metastable TiAlN by HIPIMS/DCMS co-sputtering

We review results on the growth of metastable Ti1-xAlxN alloy films by hybrid high-power pulsed and dc magnetron co-sputtering (HIPIMS/DCMS) using the time domain to apply substrate bias either in synchronous with the entire HIPIMS pulse or just the metal-rich portion of the pulse in mixed Ar/N-2 discharges. Depending upon which elemental target, Ti or Al, is powered by HIPIMS, distinctly different film-growth kinetic pathways are observed due to charge and mass differences in the metal-ion fluxes incident at the growth surface. Al+ ion irradiation during Al-HIPIMS/Ti-DCMS at 500 degrees C, with a negative substrate bias V-s = 60 V synchronized to the HIPIMS pulse (thus suppressing Ar+ ion irradiation due to DCMS), leads to single-phase NaCl-structure Ti1-xAlxN films (x less than= 0.60) with high hardness (greater than30 GPa with x greater than 0.55) and low stress (0.2-0.8 GPa compressive). Ar+ ion bombardment can be further suppressed in favor of predominantly Al+ ion irradiation by synchronizing the substrate bias to only the metal-ion-rich portion of the Al-HIPIMS pulse. In distinct contrast Ti-HIPIMS/Al-DCMSTi1-xAlxN layers grown with Ti+/Ti2+ metal ion irradiation and the same HIPIMS-synchronized V-s value, are two-phase mixtures, NaCl-structure Ti1-xAlxN plus wurtzite AlN, exhibiting low hardness (similar or equal to 18 GPa) with high compressive stresses, up to -3.5 GPa. In both cases, film properties are controlled by the average metal-ion momentum per deposited atom less thanp(d)greater than transferred to the film surface. During Ti-HIPIMS, the growing film is subjected to an intense flux of doubly-ionized Ti2+, while Al2+ irradiation is insignificant during Al-HIPIMS. This asymmetry is decisive since the critical less thanp(d)greater than limit for precipitation of w-AlN, 135 [eV-amu](1/2), is easily exceeded during Ti-HIPIMS, even with no intentional bias. The high Ti2+ ion flux is primarily due to the second ionization potential (IP2) of Ti being lower than the first IP (IP1) of Ar. New results involving the HIPIMS growth of metastable Ti1-xAlxN alloy films from segmented TiAl targets are consistent with the above conclusions.Funding Agencies|European Research Council (ERC) through an Advanced Grant; VINN Excellence Center Functional Nanoscale Materials (FunMat)</p

Comparison of Long-term Outcomes for Young and Healthy Patients with cT1a and cT3a Renal Cell Carcinoma Treated with Partial Nephrectomy

Partial nephrectomy (PN) is recommended for renal cell carcinoma (RCC) of <4 cm. We hypothesized that there is no difference in all-cause mortality (ACM) between cT1a, cT1b, and cT3a <4 cm RCC following PN. The National Cancer Database was interrogated to identify patients aged <60 yr with a Charlson comorbidity index ≤1 diagnosed between 2004 and 2017. Cox proportional-hazard models stratified for cT stage were used to predict 10-yr ACM. A total of 30 195 patients (25 121 cT1a, 4884 cT1b, and 190 cT3a <4 cm) who underwent PN with median follow-up of 64.36 mo (interquartile range 42.91-93.77) were included. Cox analysis revealed no significant difference in 10-yr ACM between cT1a and cT3a <4 cm (hazard ratio [HR] 1.05, 95% confidence interval [CI] 0.58-1.90; p = 0.88). However, the cT1b group had higher ACM (HR 1.31, 95% CI 1.15-1.48; p < 0.01). The positive surgical margin (PSM) rate was higher for cT3a <4 cm than for cT1a tumors (14.2% vs 6.3%; p < 0.01). However, there was no difference in 10-yr ACM rate between cT1a and cT3a <4 cm (10.9% vs 9.7%; p = 0.42). Our results suggest that PN is an option for cT3a RCC <4 cm, particularly in cases in which maximum nephron preservation is essential, such as patients with chronic kidney disease or a solitary kidney, although a higher PSM risk should be appreciated. PATIENT SUMMARY: We found that partial removal of the kidney for localized advanced kidney cancer is safe. The rate of surgical margins positive for the presence of tumor is higher in localized advanced kidney cancer than for less advanced cancers, but there was no difference in 10-year predicted mortality.Supports Open AccessPublished version, accepted version (12 month embargo

A review of metal-ion-flux-controlled growth of metastable TiAlN by HIPIMS/DCMS co- sputtering A Review of Metal-ion-flux-controlled Growth of Metastable TiAlN by HIPIMS/DCMS Co-sputtering

Abstract We review results on the growth of metastable Ti1-xAlxN alloy films by hybrid high-power pulsed and dc magnetron co-sputtering (HIPIMS/DCMS) using the time domain to apply substrate bias either in synchronous with the entire HIPIMS pulse or just the metal-rich portion of the pulse in mixed Ar/N2 discharges. Depending upon which elemental target, Ti or Al, is powered by HIPIMS, distinctly different film-growth kinetic pathways are observed due to charge and mass differences in the metal-ion fluxes incident at the growth surface. Al + ion irradiation during Al-HIPIMS/Ti-DCMS at 500 C, with a negative substrate bias Vs = 60 V synchronized to the HIPIMS pulse (thus suppressing Ar + ion irradiation due to DCMS), leads to single-phase NaCl-structure Ti1-xAlxN films (x ≤ 0.60) with high hardness (&gt; 30 GPa with x &gt; 0.55) and low stress (0.2-0.8 GPa compressive). Ar + ion bombardment can be further suppressed in favor of predominantly Al + ion irradiation by synchronizing the substrate bias to only the metal-ion-rich portion of the Al-HIPIMS pulse. In distinct contrast, Ti-HIPIMS/Al-DCMS Ti1-xAlxN layers grown with Ti + /Ti 2+ metal ion irradiation and the same HIPIMS-synchronized Vs value, are two-phase mixtures, NaCl-structure Ti1-xAlxN plus wurtzite AlN, exhibiting low hardness (≃18 GPa) with high compressive stresses, up to -3

Effect of shared decision making on racial and ethnic disparity in prostate cancer screening: Results from a national behavioral survey

Introduction & Objectives: The 2018 United States Preventive Services Task Force recommendations endorsed shared decision making (SDM) for men aged 55-69 and encouraged consideration of patient race and ethnicity for prostate specific antigen (PSA) screening. We sought to assess whether SDM modified the effect of race and ethnicity on the likelihood of PSA screening. Materials & Methods: A cross-sectional analysis of men aged between 55 and 69 who responded to the PSA screening portions of the 2020 U.S.-based Behavioral Risk Factor Surveillance System (BRFSS) survey was performed. Men without a diagnosis of prostate cancer who self-reported a PSA test in the previous 12 months as part of a routine examination were considered screened. SDM was defined based upon whether the respondents had been informed by a physician about the benefits and harms of PSA screening. The main predictors were patient race and the interaction between race/ethnicity and SDM. Complex weighted sample multivariable logistic regression models were fitted to test the associations. Results: Out of a weighted sample of 26.8 million men eligible for PSA screening, 25.7% (6.9 million men) reported PSA screening. In adjusted analysis, SDM was a significant predictor of PSA screening (aOR:2.65, 95%CIs:2.36-2.98, p\u3c0.001). The interaction between race/ethnicity and SDM on the receipt of PSA screening was significant (pint=0.001), meaning that the effect of race on the odds of PSA screening varied based on SDM. Among those who did not report SDM, both non-Hispanic Black (OR:0.77, 95%CIs: 0.61–0.97, p=0.026) and Hispanic (OR:0.51, 95%CIs: 0.39–0.68, p\u3c0.001) men were significantly less likely to undergo PSA screening than non-Hispanic white men. On the contrary, among respondents who reported SDM, we found no race-based differences in the odds of PSA screening (Figure 1). Conclusions: SDM was a significant predictor of PSA screening use and has a direct impact on reducing disparities in PSA screening among racial and ethnic groups